Although ibogaine gained popularity in the U.S. and Europe in the 1980s as a non-addictive treatment for drug dependency, it’s still classified as a Schedule I substance under the Controlled ...

Small, bushy, compact rose, about 90cm tall and wide, with dull greyish-green leaves. Profuse, highly fragrant, semi-double blooms of rose-red, striped with white, some blooms entirely rose-red, to ...

A variable herbaceous perennial which may be upright or trailing. Leafy stems develop from a basal rosette, topped from late summer with large sprays of star-shaped, clove-scented, pale purple-blue ...

Perry Kendall was a cofounder of Fair Price Pharma, a not-for-profit dedicated to providing low-cost Canadian access to diacetylmorphine morphine as a treatment option for individuals whose ...

I feel that it is of great clinical significance.” “For more than a decade, Takeda has been a leader in advancing the treatment of metastatic colorectal cancer in Japan. With this approval of ...

About one in 300 people worldwide are affected by schizophrenia, but for decades treatment options have been both static and limited. If the FDA approves the twice-daily pill on Thursday ...

Amgen on Tuesday reported that a pair of antibody drugs it is developing as treatments for immune-mediated diseases succeeded in late-stage trials, but the therapies did not clearly beat existing ...

These people constantly feel like they need to fall asleep,” Maxfield said. Effective treatment reduces daytime fatigue, boosting energy levels and overall alertness. AARP Membership — $12 for your ...

The global tinea pedis treatment market is on a robust growth trajectory, projected to reach a market value of USD 2,484 million by 2034, from an estimated USD 1,496.3 million in 2024. According to ...

What the team did next laid the groundwork for a potential treatment strategy against fibrosis regardless of the organ the disease attacks. Turning again to mouse models of liver, kidney and lung ...

Another report found that a state program designed to expand PrEP access through telehealth, called TelePrEP, saw significant disparities in treatment initiation. Only 10% of the people who ...